AVBP
Arrivent Biopharma, Inc.
$33.19+0.43 (1.31%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
10 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 | 2026-06-18 | Parsey Merdad | Director | Award | 13,562 | $31.74 | $430,458 | N/A | N/A |
| 2026-06-23 | 2026-06-18 | Peterson Kristine | Director | Award | 13,562 | $31.74 | $430,458 | N/A | N/A |
| 2026-06-23 | 2026-06-18 | Hohneker John | Director | Award | 13,562 | $31.74 | $430,458 | N/A | N/A |
| 2026-06-23 | 2026-06-18 | Nolet Chris | Director | Award | 13,562 | $31.74 | $430,458 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Kung Winston | CFO | Award | 140,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Lachapelle Robin | COO | Award | 130,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Lutzker Stuart | President | Award | 150,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Yao Zhengbin | CEO | Award | 550,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-04 | 2026-02-02 | Kastenmayer James Paul | General Counsel | Award | 130,000 | $0.00 | $0 | N/A | N/A |
| 2026-02-03 | 2025-12-10 | Hillhouse Investment Management, Ltd. | 10% Owner | Sale | 555,555 | $23.37 | -$12,983,320 | N/A | N/A |
AVBP
General Counsel
Award
$0
Kastenmayer James Paul130,000 shares @ $0.00
Filed 2026-02-04Trade 2026-02-02
AVBP
10% Owner
Sale
-$13M
Hillhouse Investment Management, Ltd.555,555 shares @ $23.37
Filed 2026-02-03Trade 2025-12-10